Found: 3
Select item for more details and to access through your institution.
Correction to: Eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-positive metastatic breast cancer: a phase II, multicenter, collaborative, open-label, single-arm clinical trial.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-positive metastatic breast cancer: a phase II, multicenter, collaborative, open-label, single-arm clinical trial.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 538, doi. 10.1007/s10637-019-00755-x
- By:
- Publication type:
- Article
Effect of Different Breast Densities and Average Glandular Dose on Contrast to Noise Ratios in Full-Field Digital Mammography: Simulation and Phantom Study.
- Published in:
- Radiology Research & Practice, 2018, p. 1, doi. 10.1155/2018/6192594
- By:
- Publication type:
- Article